YTHDC2 is down-expressed in lung adenocarcinoma, and is associated with the characteristics of poor differentiation, lymph node metastasis, tumor size and clinical stage of lung adenocarcinoma, and can inhibit the proliferation and migration ability of lung adenocarcinoma cells (Ma et al.2021). The gene discussed is YTHDC2; the disease is neoplasm.